Back to Top Skip to main content Skip to sub-navigation

Weed ACH moves one step closer to phase 2 of COVID vaccine plan

Image of soldier getting a vaccine in her left arm Army Spc. Arielle Castro, a preventive medicine specialist with Weed Army Community Hospital receives the Moderna COVID-19 vaccine January 12. The Leominster, Massachusetts native said she chose to get the vaccine to protect her family. (Photo by Kimberly Hackbarth, Weed Army Community Hospital.)

Recommended Content:

COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance

The Weed Army Community Hospital at Ft. Irwin, California continues to vaccinate service members and civilians, and has begun giving the second round of doses of the Moderna COVID-19 vaccine.

The start of the second doses of the COVID-19 vaccine brings Fort Irwin and the National Training Center one step closer to phase 2 of the population schema, which, according to the Department of Defense, is when healthy uniform personnel and TRICARE beneficiaries who did not meet the criteria for phase 1 can start to receive the COVID-19 vaccine.

More and more individuals eligible under phase 1 continue to opt in to receive the COVID-19 vaccine, including those who previously had the disease.

Staff at Weed ACH diagnosed Army Sgt. Traevion Williams, a patient administration department clerk with Weed ACH, with COVID-19 in July 2020.

The San Bernardino, California, native said he first lost his sense of taste and smell, followed by a high fever and excruciating body aches from COVID-19, which played a part in his decision to get the COVID-19 vaccine.

“I didn’t want to have to deal with [those symptoms] again if I didn’t have to,” he said. “If taking the vaccine was going to limit the chance of feeling like that again, I would rather just take the vaccine.”

He also chose to get the COVID-19 vaccine because of his family, he said.

“My mom is a registered nurse, and she [got the COVID-19 vaccine], so that gave me more comfort to take it knowing she’s willingly taking the vaccine,” Williams said.

Army Spc. Arielle Castro, a preventive medicine specialist with Weed ACH, explained that she originally did not want to receive the vaccine, but changed her mind because of her family and her mother’s health.

“If I want to go back home and see my mother … I feel like everybody would feel better if I got [the COVID-19 vaccine],” said the Leominster, Massachusetts, native. “I wouldn’t mind enduring the two days after getting the vaccine with the side effects in order to be able to go home.”

Side effects of the COVID-19 vaccine differ from person to person, with the most common side effect experienced by those who have received the vaccine on Fort Irwin being arm soreness at the site of the injection.

Williams received his first of the two-dose sequence of the COVID-19 vaccine December 23 with the first wave of phase 1-eligible personnel and added that he experienced arm soreness and a minor headache.

Castro detailed how she experienced symptoms including fever, body aches and chills, which are considered as normal side effects according to the Centers for Disease Control and Prevention.

Both Castro and Williams said the side effects went away in a few days.

Once all individuals who are eligible and opt in to receive the vaccine under phase 1 are vaccinated, Weed ACH will move to phase 2.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

Showing results 1 - 6 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.